Rossari Biotech Limited (NSE:ROSSARI)
India
· Delayed Price · Currency is INR 467.00
-1.95 (-0.42%)
Apr 29, 2026, 3:30 PM IST
Rossari Biotech Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2021 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | 2021 - 2017 |
| Net Income | 1,492 | 1,364 | 1,307 | 1,073 | 976.74 | Upgrade
|
| Depreciation & Amortization | 791.24 | 670.73 | 603.9 | 627.6 | 480.01 | Upgrade
|
| Other Amortization | - | - | - | 1.71 | 0.54 | Upgrade
|
| Loss (Gain) From Sale of Assets | -195.49 | 0.69 | -18.78 | -2.83 | -6.38 | Upgrade
|
| Loss (Gain) From Sale of Investments | -9.07 | -18.98 | -25.18 | -2.71 | -14.18 | Upgrade
|
| Loss (Gain) on Equity Investments | -19.01 | -9.78 | -1.75 | -9.57 | -15.54 | Upgrade
|
| Stock-Based Compensation | 33.3 | 0.68 | 6.87 | 9.43 | 18.31 | Upgrade
|
| Provision & Write-off of Bad Debts | 15.42 | 29.48 | 36.02 | 20.15 | 8.86 | Upgrade
|
| Other Operating Activities | 80.71 | 67.61 | 93.06 | 77.54 | -34.31 | Upgrade
|
| Change in Accounts Receivable | -1,349 | -853.93 | -1,126 | -286.03 | -425.28 | Upgrade
|
| Change in Inventory | -494.64 | -727.54 | -938.48 | 7.32 | -481.85 | Upgrade
|
| Change in Accounts Payable | 305.23 | 851.69 | 496.34 | 0.4 | -213.34 | Upgrade
|
| Operating Cash Flow | 650.68 | 1,374 | 432.55 | 1,516 | 293.58 | Upgrade
|
| Operating Cash Flow Growth | -52.66% | 217.75% | -71.46% | 416.24% | -38.54% | Upgrade
|
| Capital Expenditures | -2,647 | -1,585 | -1,313 | -328.76 | -382.25 | Upgrade
|
| Sale of Property, Plant & Equipment | 241.74 | 0.21 | 54.94 | 16.85 | 19.11 | Upgrade
|
| Cash Acquisitions | - | -3.15 | -177.33 | -985.31 | -3,475 | Upgrade
|
| Investment in Securities | 243.13 | -256.18 | 376.04 | -534.37 | 799.57 | Upgrade
|
| Other Investing Activities | -32.96 | 7.29 | 27.04 | 22.65 | 49.69 | Upgrade
|
| Investing Cash Flow | -2,195 | -1,837 | -1,032 | -1,809 | -2,989 | Upgrade
|
| Short-Term Debt Issued | 2,083 | 272.46 | 434.8 | 205.85 | - | Upgrade
|
| Long-Term Debt Issued | 313.07 | 934.79 | - | 449.16 | - | Upgrade
|
| Total Debt Issued | 2,396 | 1,207 | 434.8 | 655.01 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -48.12 | Upgrade
|
| Long-Term Debt Repaid | -261.54 | -416.09 | -123.93 | - | - | Upgrade
|
| Total Debt Repaid | -261.54 | -416.09 | -123.93 | - | -48.12 | Upgrade
|
| Net Debt Issued (Repaid) | 2,134 | 791.16 | 310.87 | 655.01 | -48.12 | Upgrade
|
| Issuance of Common Stock | 8.33 | 50.67 | 38.45 | 42.12 | 3,015 | Upgrade
|
| Common Dividends Paid | -27.68 | -27.65 | -27.58 | -27.53 | -27.53 | Upgrade
|
| Other Financing Activities | -251.59 | -165.17 | -159.89 | -61.05 | -21.5 | Upgrade
|
| Financing Cash Flow | 1,863 | 649.01 | 161.85 | 608.55 | 2,918 | Upgrade
|
| Foreign Exchange Rate Adjustments | -8.04 | 3.83 | -2.54 | 2.02 | - | Upgrade
|
| Net Cash Flow | 311.05 | 190.32 | -440.28 | 317.21 | 222.69 | Upgrade
|
| Free Cash Flow | -1,996 | -210.69 | -880.28 | 1,187 | -88.67 | Upgrade
|
| Free Cash Flow Margin | -8.25% | -1.01% | -4.81% | 7.17% | -0.60% | Upgrade
|
| Free Cash Flow Per Share | -36.02 | -3.81 | -15.91 | 21.44 | -1.61 | Upgrade
|
| Cash Interest Paid | - | 165.17 | 159.89 | 61.05 | 21.5 | Upgrade
|
| Cash Income Tax Paid | - | 592.04 | 538.75 | 477.77 | 501.24 | Upgrade
|
| Levered Free Cash Flow | -2,169 | -465.62 | -1,290 | 1,088 | -579.33 | Upgrade
|
| Unlevered Free Cash Flow | -1,991 | -354.3 | -1,169 | 1,227 | -500.23 | Upgrade
|
| Change in Working Capital | -1,539 | -729.78 | -1,568 | -278.31 | -1,120 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.